Ordinary Share Capital Cambiamento Data
Agios Pharmaceuticals USD 72K 0 2023-12
ALKERMES USD 1.72M 2K 2023-09
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Amgen USD 32.75B 152M 2023-09
Baxter International USD 683M 0 2023-12
Biogen USD 100K 0 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Cara Therapeutics USD 54K 0 2023-09
Eisai JPY 44.99B 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Esperion Therapeutics USD 112K 11K 2023-09
Exelixis USD 311K 9K 2023-09
Gilead Sciences USD 1000K 0 2023-09
GlaxoSmithKline GBP 1.35B 0 2023-09
Grifols EUR 119.6M 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Incyte USD 224K 0 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
Ironwood Pharmaceuticals USD 156K 0 2023-12
Merck USD 1.79B 0 2023-09
Nektar Therapeutics USD 19K 0 2023-09
Neurocrine Biosciences USD 100K 0 2023-09
Novartis USD 825M 17M 2023-09
Pfizer USD 478M 0 2023-09
Roche Holding CHF 107M 0 2023-06
Sarepta Therapeutics USD 9K 0 2023-09
Takeda JPY 1.68T 92M 2023-09
Xencor USD 611K 4K 2023-12



Nektar Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.